Hepregen Corp. Introduces Toxicity Screening Platform
Hepregen is focused on improving and commercializing its microliver platform, HepatoPac, into the drug-development pipeline of pharmaceutical and biotechnology companies.
Articles by OneMedPlace Team
Del Mar Pharmaceuticals Plans Clinical Trials for GBM Treatment
DMP estimates that the market for treating GBM patients post front-line therapy exceeds US$200 million annually in North America.
Avita Medical’s ReCell Achieves Breakthrough in Leg Ulcer Treatment
Avita Medical announces that ReCell has demonstrated a very high success rate in the treatment of chronic leg ulcers.
STR, Inc. Advances its ACL Treatment Technology after Receiving $750K in Funding from Connecticut Innovations
The product, L-C Ligament, is considered a breakthrough in the treatment of ACL tears.
Cytomedix Allows Global Pharma Company Exclusivity to Chronic Wound Healing Technology
Cytomedix announced the implementation of a letter agreement allowing an undisclosed global pharmaceutical company an exclusivity period.
STENTYS May Solve One of The Biggest Problems In Acute Coronary Syndrome
Gonzague Issenmann, CEO and co-founder of STENTYS, spoke with OneMedRadio and shared his insights on the industry and how the company has become a success.
Teribone Treats Osteoporosis With Noninvasive Systematic Approach
It was announced this week that Zosano Pharma, Inc. (Zosano) and Asahei Kasei Pharma (AKP) formed a collaboration to develop Teribone (teriparatide acetate), a transdermal patch treatment for osteoporosis.
Fibromyalgia Treatment Re-Engineered to Reach Unmet Medical Conditions
TONIX Pharmaceuticals announced the publication of data in the peer-reviewed journal, The Journal of Rheumatology, demonstrating an improvement in core symptoms associated with FM.
Protected: VIDEO: Talking JOBS Act with Christine Jacobs, SEC Advisory Committee Chair
There is no excerpt because this is a protected post.
Protected: OneMedRadio: The JOBS Act — Promises and Pitfalls
There is no excerpt because this is a protected post.